Anesthesia Medical News about INTESTINAL PEPTIDE

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vasoactive intestinal peptide and pituary adenylate cyclase-activating polypeptide inhibit tissue factor expression in monocyte in vitro and in vivo
Shock, 01/15/09

Lv B et al. - Interestingly, VIP and PACAP block both the migration of c-Rel/p65 and the phosphorylation of p38 and JNK, as demonstrated by Western blot analysis. These data indicate that VIP and PACAP inhibit LPS-induced TF expression in monocytes in vitro and in vivo, confirming these peptides as candidates for the multitarget therapy of septic shock.

<< Previous
Intestinal cytoskeleton degradation precedes tight junction loss...

Next >>
The systemic and pulmonary lps binding protein response to...

A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa
Mucosal Immunology, 10/08/09 Relevance Score: 67%

Identification and Characterization of a Small Molecule Antagonist of Human VPAC2 Receptor
Molecular Pharmacology, 11/10/09 Relevance Score: 65%

Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins
European Journal of Nutrition, 11/09/09 Relevance Score: 65%

Identification and Characterization of a Small Molecule Antagonist of Human VPAC2 Receptor
Molecular Pharmacology, 11/02/09 Relevance Score: 65%

Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes
British Journal of Dermatology, 10/05/09 Relevance Score: 64%